Featured:
Celebrating innovation: the PRINCIPLE-PANORAMIC Celebratory Symposium
17 April 2024
Researchers, clinicians, supporters and PPI contributors gathered on Monday to celebrate the innovative PRINCIPLE and PANORAMIC clinical trials that evaluated potential treatments for COVID-19 during the pandemic and broke recruitment records for community-based trials in doing so. Both trials were run by the Clinical Trails Unit (CTU) in (NDPCHS).
Celebrating collaboration and resilience: The PRINCIPLE PANORAMIC art exhibition
21 March 2024
Celebrate the resilience and collaboration behind Oxford's groundbreaking PANORAMIC and PRINCIPLE COVID-19 trials through "The PANORAMIC PRINCIPLE" exhibition. Artist Tanya Poole's powerful portraits honour the diverse array of participants, researchers, and medical professionals whose inclusive efforts set global benchmarks and transformed lives. An inspiring tribute to human determination in the face of adversity.
New study shows ivermectin lacks meaningful benefits in COVID-19 treatment
13 March 2024
New research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population.
PANORAMIC trial finds molnupiravir may not be a cost-effective treatment for COVID-19 in at-risk adults
28 January 2024
A new evaluation from the University of Oxford’s ongoing PANORAMIC trial suggests that an antiviral treatment, called molnupiravir, used to treat COVID-19 may not be cost-effective at its current price of £513 per course, compared to usual NHS care and support, in the first six months after infection. However, it may be beneficial for patients over the age of 75.
Nuffield Department of Primary Care Health Sciences set to deliver clinical trials expertise to China National Biotec Group in new collaboration
28 November 2023
Clinical trials Global perspective
The training initiative builds the foundations to explore further collaborations encompassing joint research efforts, leadership programmes, and a shared commitment to advancing clinical trials.
New Oxford Study Shows Brief Sleep Therapy Delivered by Nurses Improves Insomnia
11 August 2023
Cardiovascular & metabolic Clinical trials Policy & health systems
Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
Rapid weight loss found to be safe and helpful for people with liver disease, Oxford trial reveals
28 June 2023
Cardiovascular & metabolic Clinical trials Health behaviours
A clinical trial, led by a team at NDPCHS, has shown that a three-month rapid weight loss programme was not only safe but also effective in reducing the severity of a liver disease called non-alcoholic steatohepatitis (NASH) with liver fibrosis.
Multi-cancer blood test showed ‘real promise’ in NHS trial
2 June 2023
An NHS trial of a new blood test for more than 50 types of cancer, led by the University of Oxford, correctly revealed two out of every three cancers among over 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.
Introducing Proxemis: the University of Oxford and EMIS have announced a new joint venture, Proxemis, an end-to-end clinical trial solution
4 May 2023
Clinical trials Digital health & innovation
Combining the world-renowned expertise of the Nuffield Department of Primary Care Health Science's Clinical Trials Unit with the software and data management capabilities of EMIS, Proxemis is reimagining research to support healthier lives with a uniquely tailored experience for clinical trial delivery.
Professor Chris Butler addresses the UN on PANORAMIC - BAPS UK & Europe collaboration
24 January 2023
COVID-19 Clinical trials Public engagement & involvement
Recently, Professor Chris Butler addressed the United Nations regarding the PANORAMIC Trial and the assistance of BAPS UK & Europe.
PANORAMIC trial finds molnupiravir does not reduce COVID-19 hospitalisation/deaths in vaccinated people at high risk
22 December 2022
Researchers from the University of Oxford have today released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial.
Clinical Trials Day 20 May 2022 - “We couldn’t do it without you.”
17 May 2022
Clinical Trials Day gives us an opportunity to reflect on, and appreciate, recent achievements and the people who have made these achievements possible. So, this year we want to say a big thank you to everyone involved, “we couldn’t do it without you”.
The PRINCIPLE Trial - two years on
16 May 2022
The PRINCIPLE Trial has led the way in evaluating treatments for COVID-19 in the community over the last two years.
Self-monitoring of blood pressure does not result in the earlier detection of high blood pressure in pregnancy nor does it improve blood pressure control in those with pregnancy hypertension
3 May 2022
Clinical trials Patient experience
Self-monitoring of blood pressure during pregnancy neither results in earlier detection of high blood pressure, nor helps with blood pressure control in those who are pregnant, suggest the results of two new papers based on research from the University of Oxford and King’s College London (funded by the National Institute of Health and Care Research).
Primary care research nurses nominated for OUH Award
13 April 2022
Awards & appointments COVID-19 Clinical trials
Congratulations to the amazing team of research nurses working in the Primary Care Clinical Trials Unit who have been shortlisted as finalists in the Oxford University Hospitals NHS Foundation Trust Staff Recognition Awards 2021.
10,000 people join the PRINCIPLE Trial – A huge ‘Thank You’ from us all.
4 April 2022
10,000 people have joined the PRINCIPLE Trial over the last two years and we want to say a big ‘Thank You’ to them all for their amazing contribution to testing treatments for COVID-19 in the community.
PANORAMIC hits the 20,000 participant milestone
31 March 2022
The world’s largest study of community-based treatments for acute COVID-19 has reached a world-first, historic milestone: over twenty thousand participants from across the UK have now taken part in the PANORAMIC trial.
Recruitment begins for national community COVID-19 antiviral trial
8 December 2021
COVID-19 Clinical trials Public engagement & involvement
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
Blog: Opinions from our research and teaching
Contact our communications team
Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.